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Abstract
Background: Parents often do not consider fever as an important physiological response and mechanism of
defense against infections that leads to inappropriate use of antipyretics and potentially dangerous side effects. This
study is designed to evaluate the appropriateness of antipyretics dosages generally administered to children with
fever, and to identify factors that may influence dosage accuracy.
Results: In this cross-sectional study we analyzed the clinical records of 1397 children aged >1 month and < 16 years,
requiring a primary care (ambulatory) outpatient visit due to fever. We evaluated the number of children who had
received >90 mg/kg/day of acetaminophen, the prescriber, the medication formula and the educational level of the
caregiver who administered acetaminophen. Among those children included in our study, 74 % were administered
acetaminophen for body temperature≤ 38.4 °C. 24.12 % of children received >90 mg/kg/day of acetaminophen.
Parents with university qualifications most commonly self-administered acetaminophen to their children, in a higher
than standard dose. Self medication was also described in 60 % of children, whose acetaminophen was administered
for temperatures < 38 °C. Acetaminophen over-dosage was also favored by the use of drug formulations as drops or
syrup.
Conclusions: Our study shows that preventive action should be taken regarding the use of acetaminophen as
antipyretic drug in children in order to reduce the fever phobia and self-prescription, especially of caregivers with
higher educational levels. It is also necessary to promote a more appropriate use of acetaminophen in those parents
using drops or syrup formulations.
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Background
In recent years a fever phobia phenomenon [1] has been
recognized among parents, who consider fever as a health
danger instead of an important physiologic response and a
mechanism of defense against infections [2, 3].
This phenomenon, associated with an increase in self-
medication [4] has resulted in inappropriate use of anti-
pyretics, amongst which the most commonly used is
acetaminophen [5, 6].
The dosage of acetaminophen in children is assessed ac-
cording to weight [7]; thus a wrong weight measurement or
wrong perception of the child’s weight can lead to inappro-
priate medication dosing. Also, dosing based on age may
cause errors in overweight or underweight children [8–10].
Actually, the appropriate dosage of acetaminophen in chil-
dren is 10–15 mg/kg/dose administered every 4–6 h [11].
Higher doses of acetaminophen may be hepatotoxic, thus its
administration should be performed carefully. Acetamino-
phen toxicity may be consequent to the administration of
higher dosages both for over-dosages (in terms of quantity
per dose) and more frequent standard doses (in terms of
frequencies) of acetaminophen or excessive in numbers of
administrations per day in 24 h, causing a daily overdose
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of > 90 mg/kg/day [11–17]. Other authors [14, 18] have de-
scribed adverse effects even with doses of 75 mg/kg/day,
however they were not able to clarify what conditions may
be responsible for the onset of toxicity in some children,
while the same doses have been shown not to be toxic for
matched groups of patients. In regards, the Italian Society of
Pediatrics suggest the daily maximal dose of acetaminophen
of 80 mg/kg/day, defining toxic a dose of 150 mg/Kg [19].
The pediatric acute and emergency departments are pri-
vileged areas to observe how acetaminophen is used by
caregivers in cases of fever. The study was performed on
children admitted to the acute care and emergency de-
partments of some Hospitals in the Lazio region. The ob-
jective of our study was to evaluate the appropriateness of
the dosage of acetaminophen generally administered to
children with fever, and the factors that may influence
dosage accuracy.
Methods
We performed an observational cross-sectional study in a
period of six months, in accordance with STROBE guide-
lines [20] from November 2012 to April 2013.
The study setting is made of three health care services
(General Paediatrics Operative Unit, Grassi Hospital of
Rome, Policlinico Umberto I of Frosinone and General
Paediatrics Operative Unit, Vittorio-Emanuele Hospital,
Catania) affiliated to SIMEUP (Italian Society for
Pediatric Emergency). Children aged between 1 month
and 16 years, who required a primary care outpatient
visit due to fever, to whom acetaminophen was adminis-
tered by caregivers as antipyretic drug, from almost
24 h, were enrolled in this study.
In the pediatric emergency department, caregivers were
asked to respond to a questionnaire inquiring on: the age
and weight of the child, if acetaminophen was administered
before entering the hospital, the dosage and frequency of
administration, type of medication: liquid (syrup or drops)
or solid (suppositories or tablets), the underlying body
temperature that prompted the administration of medica-
tion, if other antipyretic drugs had been administered be-
fore, parent’s nationality, the parent giving the medication,
level of education, and the name of the prescriber. At ques-
tionnaire administration, a healthcare physician explained
how to fill the form to the parents.
Exclusion criteria were applied to the following
categories:
– Children with fever to whom no antipyretic drug
was administered
– Children with fever to whom acetaminophen was
not administered as antipyretic
– Children taking antipyretics other than
acetaminophen,
– Children with incomplete questionnaires,
– Children whose parents were of different
nationalities (for example one Italian and one with a
foreign nationality). These patients were excluded to
reduce the potential for bias related to different
cultural behaviors.
The primary outcome of the study was to evaluate the
dosage of acetaminophen administered both as mg/kg/
dose and as total daily quantity in mg/kg/day. Dosage of
up to 15 mg/kg/dose (group A) was considered normal.
Dosage of more than 15 mg/kg/dose (group B) was
considered as supratherapeutic [11, 14]. Also the daily
quantity (mg/kg/dose × n° of doses) was considered as not
potentially dangerous if < 90 mg/kg/die (group C) or
potentially dangerous if > 90 mg/kg/day (group D), [11].
Secondary outcomes were the temperature for which
antipyretics were used and the factors that could influ-
ence medication’s dosages, such as:
– Educational level of the caregiver who administered
acetaminophen to the child (elementary school,
primary school, secondary school, university
education)
– Type of prescription: medical or self-prescription
– Pharmaceutical formulation: liquid, drops or syrup,
(DSy group) or solid, tablets or suppositories,
(TSu group).
– Parents nationality, differentiating couples of parents
as Italians (I) and Foreigners (F)
Statistics
Data is analyzed with JMP 10 for mac.
Chi-square was used for differences between groups of
categorical variables.
Wilcoxon test was used for analyzing the differences
between different quantities of acetaminophen. Because
estimating, initially, the approximation of population distri-
bution to normal by Kolmogorov-Smirnov One-Sample
Test and statistics for kurtosis and symmetry, it was
asymmetrically distributed and non-parametric tests
were used. Results for each studied group were expressed
as median/3 rd quartile/1 st quartile
A p value of < 0.05 is considered as statistically
significant.
Also, a contingency analysis was used to verify the dis-
tribution of patients with respect to the caregivers’ nation-
ality and the daily dose of administered acetaminophen.
Study approval
The protocol conforms to the ethical guidelines of the
1975 Declaration of Helsinki as revised in year 2000, and
was approved by the institution’s ethical committee [21].
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Results
A total of 2108 children who were admitted to Acute
and Emergency Departments because of fever were se-
lected for this study. At baseline 203 children to whom
no antipyretic drug was administered were excluded.
Also 108 children, who used other antipyretic drugs and
95 children who assumed acetaminophen plus another
different antipyretic drug were excluded. Parents of
those children included in the study were asked to fill an
evaluation questionnaire. After collecting questionnaires,
289 children were excluded as their parents did not fully
fill the questionnaire. Sixteen other children were also
excluded because their caregivers’ questionnaire showed
that their parents were of different nationality. Thus,
a total of 1397 questionnaires were analyzed. Median
age of children was 72 months (with 3 rd quartile of
118 months and 1 st quartile of 48 months).
Acetaminophen was administered in 74 % of cases
to children with a body temperature below 38.4 °C
(Fig. 1).
As shown in Table 1, the daily dose of acetaminophen
was < 90 mg/kg/day (group C) in 1060 (75.88 %) cases
and > 90 mg/kg/day (group D) in 337 (24.12 %) cases.
Among those who assumed more than 90 mg/kg/day
(group D), Acetaminophen was administered more than
15 mg/kg/dose in 97.63 %, while the remaining 2.37 %
received less than 15 mg/kg/dose, with a higher frequency
with respect to standard during the 24 h (Table 1).
Data on Table 2 shows that in group C (daily
dose < 90 mg/kg/day), the educational level of the care-
giver who administered acetaminophen to his/her child,
was secondary education in 63 % cases, primary education
in 33 % and an elementary education in 4 %, while in
group D (daily dose > 90 mg/kg/day) was university degree
in 71 % of cases and a secondary degree in 29 %. As a mat-
ter of fact Table 2 shows that the caregiver responsible for
the administration of higher daily doses of acetaminophen
is the one with a higher educational level (caregiver with a
university degree: dose/day 121.73 ± 22.89 mg).
Acetaminophen was administered as tablets or sup-
positories (group TSu) in 87.97 % of children and drops
or syrup (group DSy) in 12.03 %. The daily dose of acet-
aminophen (mg/kg/day) was significantly higher in those
who assumed drops or syrup rather than those who
assumed tablets or suppositories, both for children in
group C (dose/day < 90 mg/kg/day) [the dose is expressed
as median (3 rd quartile/1 sd quartile)], [DSy vs TSu: 69.81
(80.97/52.63) vs 57.69 (71.91/44.44) p < 0.003; DSy 5 %,
TSu 95 %] and those in group D (dose/day > 90 mg/kg/die)
[DSy vs TSu: 117.65 (133.33/100) vs 105.63 (116.28/96.38)
p < 0.0001; DSy 35 %, TSu 65 %]. Moreover, odds ratio re-
vealed a higher risk of acetaminophen overdose when
drops and/or syrup formulations were used, OR = 0.089
(lower 95 % = 0.061 Upper 95 % =0.13)
Finally, acetaminophen was prescribed by a health
professional for 85.7 % of children, while for 14.3 % of chil-
dren acetaminophen was self-prescribed by parents, the
latter all included in group D (dose/day >90 mg/kg/day).
Consequently, acetaminophen overdose was detected in
9.82 % of children, even with a medical prescription
(Table 1).
As highlighted by the contingency analysis in Table 3,
the caregivers’ nationality to whom acetaminophen
was prescribed, was equally distributed between Italians (I)
and Foreigners (F) both in group C (dose/day < 90 mg/kg/
day) and in group D (dose/day > 90 mg/kg/day). No statis-
tically significant differences have been observed, with
respect to nationality, between those patients assuming
doses < or > 90 mg/kg/day of acetaminophen (Chi-square
test p NS). Moreover, the dose/day evaluation according to
the nationality of the caregivers who administered the drug
has not shown any statistically significant difference be-
tween group C and D. Also, the odds ratio analysis has
not shown a significant risk with respect to caregivers’ na-
tionality, OR = 0.80 (lower 95 % = 0.56, upper 95 % = 1.14)
Finally, a specific analysis was performed for those
children who were treated with acetaminophen for body
temperatures under 38 °C. These represented 21 % of
the included children (293 patients), with a median age
of 75 months, (a 3rd quartile of 106 months and 1 st
quartile of 53 months), in whom the parent administering
the drug had secondary education in 52 % of cases. Among
these patients, 72 % consumed less than 90 mg/kg/day,
prescribed by a doctor only in 40 % of cases. This
percentage was significantly lower than patients with fever
over 38 °C (Chi-square test p < 0.01).
Discussion
In this study, we indicated that 74 % of caregivers start
antipyretics at temperatures < 38,4 °C. Among them,
71.57 % administer it between 38 and 38.4 °C, and 21.00 %
under 38 °C (Fig. 1). This attitude surely reflects a
widespread fever phobia that leads to early antipyretic
administration. Literature data have already described this
attitude among caregivers and pediatricians [22–24], justi-
fied by the attempt of reducing the discomfort generated
by fever. This therapeutic attitude is in contrast with
other guidelines indicating pharmacological treatment
when temperature is >40 °C or > 39 °C if the child is
in discomfort [25].
Moreover about 24.12 % of our patients assumed a
daily dose of acetaminophen higher than 90 mg/kg/day,
of which in 97.63 % of cases a high quantity of drug was
administered in a single daily dose, and not a higher
frequency of administration (Table 1), as opposed to
what was described in a study by James et al [26]. The
assumption of higher doses of self-prescribed acetamino-
phen by the caregiver was 14.3 % in the studied population.
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This attitude of autonomous choices was more frequent
in those caregivers with a higher level of education who
should have better understood that acetaminophen is
effectively a drug and not just an over-the-counter
product, avoiding its superficial use, as evidenced by
McCloskey et al [27]. This behavior has also been
described in healthcare students, in which their higher
knowledge on drugs seems to favor the phenomenon of
self-medication [28]. Self-prescription phenomena strictly
relate to the administration of high dosages of acet-
aminophen [1, 29].
In our study self-medication was detected in 60 % of
children to whom acetaminophen was administered for
body temperature <38 °C, but with doses <90 mg/kg/day
in 72 % of cases.
The results of our study also highlight the preventive
efficient role of the general practioners in the education for
the right prescription and assumption of acetaminophen in
Fig. 1 Body temperature to which the parents reported to have begun to treat the fever
Table 1 Subgroups of the studied population accordingly to the total daily dose (group D > 90 mg/kg/day; Group C < 90 mg/kg/die)
and the single daily dose (group A < 15 mg/kg/dose; group B > 15 mg/kg/dose;) of assumed acetaminophen




mg/kg/day Sub-group dose N (%) mg/kg/dose N. of doses mg/kg/day
Median Median Median Median
3 rd quartile 3 rd quartile 3 rd quartile 3 rd quartile
1 st quartile 1 st quartile 1 st quartile 1 st quartile
Group D 337 (24.12) 9,82/14.3 107.14 <15 mg/kg/dose (Group A) 8 (2.37) 13.39 8.00 107.10
14.76 8.00 118.10
123.71 11.94 8.00 95.52
>90 mg/kg/day >15 mg/kg/dose (Group B) 329 (97.63) 19.53 6.00 107.14
97.61 22.73 6.00 123.97
17.24 5.00 97.66
Group C 1060 (75.88) 75.88/0 58.20 <15 mg/kg/dose (Group A) 703 (66.32) 11.68 4.00 52.63
13.44 6.00 68.18
73.13 9.62 4.00 39.06
<90 mg/kg/day >15 mg/kg/dose (Group B) 357 (33.68) 18.11 4.00 68.9644.78
20.00 4.00 76.92
16.67 3.00 61.68
Group D vs C (mg/kg/day) p < 0.001
Group D: Sub-group A vs Sub-group
mg/kg/dose p < 0.0001; number of doses p < 0.0001; mg/kg/day p NS
Group C: Sub-group A vs Sub-group B
mg/kg/dose p < 0.0001; number of doses p < 0.0001; mg/kg/day p < 0.0001
mg/kg/dose for C vs D sub-groups
CA vs DB; DB vs CB; DA vs CB p < 0.0001 – DA vs CA p NS
Number of doses for C vs D sub-groups
CA vs DB; DB vs CB; DA vs CB; DA vs CA p < 0.0001
mg/kg/day for C vs D sub-groups
CA vs DB; DB vs CB; DA vs CB; DA vs CA p < 0.0001
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childhood. In fact all the patients assuming a proper dose
(less than 90 mg/kg/day) had a medical prescription and
only 9.82 % of the studied population, assumed a dose of
more than 90 mg/kg/day with a medical prescription. This
evidence is in contrast with the results of other data which
related the problem of acetaminophen overdose to a wrong
prescription by the primary care physician [30], as to re-
spond to the anxiety of family members, who seek an im-
mediate resolution of their child’s fever [23].
Finally, it is important to mention the assumption of
the drug as drops and syrup, (as seen in 12.03 % of the
studied population), was associated with extra doses of
acetaminophen, as described by other authors, who also
proposed the use of simpler systems to better highlight
the appropriate dosage of acetaminophen [29–32] .
Conclusions
We believe that further interventions should be done to
improve the knowledge of caregivers on the correct use
of acetaminophen. Also the physiological protective role
of fever, parent’s responsibility in following the pediatri-
cian’s prescription precisely, avoiding the self-prescription
phenomenon both concerning the timing to start acet-
aminophen and the administered doses should be empha-
sized in general population.
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